I assure you of one thing...
LPC's OS affiliates will
I assure you of one thing...
LPC's OS affiliates will see to it we have a 10-bagger on this one
what exactly does that mean?
it means $0.68 pps
from the time the new LPC share structure was approved by the SEC in the 1st week in May, consistent OS affiliate positions have been taken almost daily, starting at $0.068 - check the charts - the affiliates have built a foundation well below $0.17 - and will continue to average up from here...
we are in exceptional company with LPC and their affiliates - and AMBS has the goods to deliver
2H14 we'll see a minimum but conservatively stated highs between:
$0.48 = $350-Mil. FMV
and
$0.68 = $500-Mil. FMV
that said, with a $35-$50Mil. JV cash stake in LymPro alone - this is all easily accomplished on a lowly 10 x forward looking PE multiple's
mark this post - my name and credibility are on the line
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A cruise operator does not order ships for 2035 because it is feeling timid. Carnival is laying out a long runway of hardware, private-destination capacity and onboard-to-onshore spending hooks, all aimed at keeping guests inside its ecosystem longer. For NYSE:CCL, this is not a next-quarter story. It is a very public statement that management sees enduring appetite for...
Continue Reading
A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...
Continue Reading
Laboratory AI gets interesting only when it reaches the hardware bench, and Danaher is taking a serious swing at that ugly, complicated job with Microsoft. The Nov. 20 partnership is not just another chatbot bolted onto a dashboard. It is aimed at building a common agentic platform that can help instruments interpret scientific intent, guide setup, control hardware within...
Continue Reading
Rayong just became a much louder pin on Asia's industrial map. Birla Carbon has inaugurated a 120 kMT carbon black plant in Thailand, and the significance is bigger than a ribbon-cutting photo. This is a capacity-and-location move aimed squarely at the uncomfortable part of industrial supply chains: customers need material when they need it, not after it has spent weeks...
Continue Reading
Revenue can wear a fancy suit while earnings arrive in work boots, and RLX Technology's third quarter is exactly that kind of report. The newly consolidated European distribution business pushed third-quarter revenue to RMB1.92 billion, up 69.7% year over year. That is a real jump, not pocket change. But the same acquisition also changed the mix, squeezed the blended...
Continue Reading
Scientific software rarely loses users because the underlying model is too clever; it loses them because getting through the front door is a nuisance. Wenge AI has addressed that unglamorous problem by adding Google and Apple sign-in options to the international version of ScienceOra, its AI-powered research and decision-support platform. This is not the sort of...
Continue Reading
A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...
Continue Reading
Three proposed takeovers, three very different headaches, and one familiar question that never gets old: are regular shareholders actually receiving the best available deal? On Nov. 20, 2026, investor-rights law firm Halper Sadeh LLC said it was investigating the proposed transactions involving Penske Automotive Group, Werewolf Therapeutics and Personalis for potential...
Continue Reading
China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...
Continue Reading
Thanksgiving has a nasty habit of turning perfectly ordinary earnings dates into ghost towns, and Sivers Semiconductors has sensibly stepped around that pothole. The company will publish its third-quarter 2026 interim report on Monday, November 30, rather than Thursday, November 26. That is not a strategy reset, a warning, or some grand corporate mystery. It is a calendar...
Continue Reading
Top 5 Most Recently Viewed Articles
InfoSync Services Partners with CogentHub for Strategic Growth In a significant move for the professional services landscape, InfoSync Services, a renowned provider of outsourced solutions, has been sold from Staple Street Capital to CogentHub. This transition marks an exciting chapter not only for InfoSync but also for its clients and the wider market. Understanding...
Continue Reading
China's Proposal for Economic Stimulus Amid global economic strains, a well-regarded former central bank adviser has put forth a notable idea: China could consider issuing ultra-long-term treasury bonds, which might generate an impressive 10 trillion yuan (around $1.4 trillion) in stimulus. This proactive suggestion was shared at the China Macroeconomy Forum and...
Continue Reading
Strategic Growth Plans for Cavitation Technologies, Inc. Cavitation Technologies, Inc. (OTCQB: CVAT) is committed to advancing its innovative capabilities in the fields of water treatment and beverage technology. As the company looks toward the future, it aims to capitalize on existing technologies while exploring new partnerships that will enhance its operations....
Continue Reading
How Insulet Has Thrived Over the Years Insulet (NASDAQ:PODD) has shown remarkable performance, exceeding market expectations over a 15-year span with an impressive annualized return of 23.78%. This is a testament to strong financial growth, significantly outperforming many competitors. The Incredible Growth of a $1000 Investment Consider this: imagine if you invested...
Continue Reading
Synovus Financial Corp. at the BancAnalysts Association Conference Synovus Financial Corp. (NYSE: SNV) is preparing for its participation in a highly anticipated conference that gathers financial experts and analysts. The event will feature a fireside chat with the company’s leadership, including Chairman, CEO, and President Kevin Blair along with Executive Vice...
Continue Reading